Toxoplasma gondii Antibody, IgG and IgM
Toxoplasmosis is a disease caused by the parasite Toxoplasma gondii. Toxoplasma gondii is an obligate intracellular protozoan that causes human infection via ingestion, transplacental transfer, blood products, or organ transplantation. Cats are the definitive hosts of T. gondii and pass oocysts in their feces. Human are intermediate hosts and infection occurs through ingestion of sporulated oocysts from undercooked meats or from ingestion of food or water contaminated with cat feces. Fetuses acquire the infection via the transplacental route.
Serological testing is important in diagnosing toxoplasmosis because culture of the T. gondii organism is difficult, and most laboratories are not equipped to culture the organism. Testing is also available on most immunoassay platforms. Testing consists of either IgG or IgM antibodies. It is estimated that more than 60 million people in the United States are infected with T. gondii organism. In most normal adults, infections are asymptomatic. In those with clinical syptoms, the most common is lymphadenopathy, which may be accompanied by various other nonspecific symptoms. The greatest concern is in those who are immunocompromised, or the fetus of a previously uninfected mother, because the organism is capable of crossing the placenta. Infection during pregnancy may result in the child being blind, having mild to severe CNS damage, or death. Women who are exposed to the parasite before pregnancy do not transmit the parasite to the fetus. However, if infected during the pregnancy it can be transfered to the fetus. Most infections in immunocompromised patients are thought to be due to reactivation of latent infection, and many involve the central nervous system. The severity of congenital infection in utero declines as the pregnancy progresses. The majority of infants infected in utero show no symptoms at birth. Unrecognized asymptmatic infection during pregnancy may result in early delivery and intellectual, adiologic and neurologic deficts later in life.
In the immunodeficient host, acute infection may progress to meningoencephalitis, pneumonitis, or myocarditis. Immunocompromised patients often do not produce enough antibody to be detected by serological testing. Therefore, PCR testing of CSF may prove beneficial. In acute primary infection, IgM antibody develops 1 to 2 weeks after onset of illness, peaks in 6 to 8 weeks, and then declines. IgG antibody develops on a similar time course but persists for years. In adult infection, the disease usually represents a reactivation, not a primary infection. Therefore, the IgM test is less useful in these cases. Approximately 30% of all US adults test positive for antibody to T. gondi.
Single IgG titers of >1:256 are considered diagnostic of active infection; titers of >1:128 are suspicious and should be confirmed by repeat analysis or by PCR. Titers of 1:16 – 1:64 may merely represent past exposure. If titers subsequently rise, they probably represent early disease. High titer IgG antibody results should prompt an IgM test. IgM, however, is generally not found in adult AIDS patients because the disease usually represents a reactivation. IgM titer >1:16 is very important in the diagnosis of congenital toxoplasmosis. Some recommend ordering baseline toxoplasma IgG titers in all asymptomatic HIV-positive patients because a rising toxoplasma titer can help diagnose CNS toxoplasmosis in the future. It is important to know that most of the serology tests run today use IU/mL rather than titers. Therefore, if antibodies are present in the higher levels it would mean higher titers.
- Diagnosis of T. gondii infection
- In diagnosis of acute, recent, or reactivated toxoplasma infection
- Differential diagnosis of acute congenital toxoplasmosis
- To determine (IgM) recent serological response to toxoplamsa
- Assessment of a patient's immunological resonse from individuals including women of childbearing age
Increased in:
- Acute or congenital toxoplasmosis (IgM)
- Acute, recent, or reactivated toxoplasma infection (IgM and IgG)
- Past infection or exposure to toxoplasma (IgG)
- SLE, HIV infection, rheumatoid arthritis (false-positive)
Note: IgG positivity in patients less than 6 months of age may be due to maternal antibody acquired in utero.
If IFA is used, titers are used for results.
If immunoassay is used, IU/mL and index values (IV) are used.
IgG:
- < 6IU/mL – Negative
- 6 – 9 IU/mL – equivocal
- >9 IU/mL – Positive
IgM:
- 0.9 - 1.10 IV – Equivocal
- >1.10 IV – Positive
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
CSF
Stability
- Ambient: 48 hours
- Refrigerated: 14 days
- Frozen: 60 days
- Br J Biomed Sci. 2002;59:4. [PMID: 12000186]
- J Infect Dis. 2002;185 (Suppl 1):S73. [PMID: 11865443]
- Trans R Soc Trop Med Hyg. 2002;96 (Suppl 1):S205. [PMID: 12055840]
- Murray PR et al (editors). Manual of Clinical Microbiology 8th ed. ASM Press (2003).
- Clin Perinatol. 2005;32:705. [PMID: 16085028]
- Stevens CD. Clinical Immunology & Serology: A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company (2010).